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ABSTRACT
There are 2. 4 million annual neonatal deaths worldwide. 
Simple, evidence- based interventions such as temperature 
control could prevent approximately two- thirds of these 
deaths. However, key problems in implementing these 
interventions are a lack of newborn- trained healthcare 
workers and a lack of data collection systems. NeoTree 
is a digital platform aiming to improve newborn care in 
low- resource settings through real- time data capture 
and feedback alongside education and data linkage. This 
project demonstrates proof of concept of the NeoTree as a 
real- time data capture tool replacing handwritten clinical 
paper notes over a 9- month period in a tertiary neonatal 
unit at Harare Central Hospital, Zimbabwe. We aimed to 
deliver robust data for monthly mortality and morbidity 
meetings and to improve turnaround time for blood culture 
results among other quality improvement indicators. There 
were 3222 admissions and discharges entered using the 
NeoTree software with 41 junior doctors and 9 laboratory 
staff trained over the 9- month period. The NeoTree 
app was fully integrated into the department for all 
admission and discharge documentation and the monthly 
presentations became routine, informing local practice. 
An essential factor for this success was local buy- in and 
ownership at each stage of the project development, as 
was monthly data analysis and presentations allowing 
us to rapidly troubleshoot emerging issues. However, the 
laboratory arm of the project was negatively affected 
by nationwide economic upheaval. Our successes and 
challenges piloting this digital tool have provided key 
insights for effective future roll- out in Zimbabwe and other 
low- income healthcare settings.
PROBLEM
At Harare Central Hospital (HCH), 
Zimbabwe, 12 000 babies are born each year, 
and the 100- cot tertiary neonatal unit often 
runs at 140% capacity, admitting babies locally 
and nationwide for surgical management. 
Prior to this pilot quality improvement 
project, documentation was paper based, 
and accessing records for audit and research 
purposes was laborious and unrewarding, 
with excessive record loss. Quantification of 
basic data such as admission rates was chal-
lenging, let alone measuring quality indica-
tors. Junior doctors spend 2 months on the 
unit, and senior support is overstretched. 
Junior doctors may have little experience of 
managing sick neonates, particularly identi-
fying and managing sepsis acutely, and inap-
propriate antibiotics may be used (eg, using 
adult rather than neonatal guidelines). Nearly 
60% of babies are admitted with presumed 
sepsis.1 A recent Klebsiella pneumoniae sepsis 
outbreak in the unit had 33% case fatality, 
and control interventions were hindered by 
delayed and lost results from the laboratory. 
Prior to this study, retrieval of microbiology 
results involved a doctor going in person to 
the laboratory in a separate building on site, 
with a median turnaround time of 6 days.1 
Delays in feedback of negative blood culture 
results likely prolonged admission and anti-
biotic therapy while delays in positive culture 
results likely led to ineffective/excessively 
broad antimicrobial therapy, depending on 
sensitivities. At baseline, 98% of admitted 
babies received antibiotics at admission, and 
99% received oral amoxicillin at discharge, 
which is not an evidence- based intervention.1
NeoTree is a digital quality improvement 
platform codeveloped with Malawian health-
care workers to improve newborn care in 
low- resource settings.2 It offers education, 
decision support and suggested management 
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plans according to national and WHO guidelines along-
side real- time data collection. The user- facing component 
is a tablet- based Android application (app).
Aims:
1. Demonstrate proof of concept as a real- time data cap-
ture tool, replacing handwritten paper- based admis-
sion/discharge forms over a 9- month period.
2. Deliver robust reliable data for the monthly neona-
tal unit morbidity and mortality meetings (within 6 
months).
3. Improve the availability of data for diverse quality im-
provement projects.
4. Demonstrate proof of concept of NeoTree as a surveil-
lance tool for neonatal sepsis and antimicrobial use, 
including reducing turnaround time for blood culture 
results.
BACKGROUND
Of 2.4 million annual neonatal deaths,3 ~60% could be 
prevented through instigation of simple, evidence- based 
practices such as temperature control.4 Efforts to improve 
survival are hampered by limited data collection, making 
it difficult to identify modifiable risk factors for mortality. 
This renders benchmarking and quality improvement 
measures challenging to implement.5
Sepsis is implicated in ~25% of neonatal deaths, and many 
surviving babies experience chronic morbidity.6 In low- 
income settings, overcrowding, understaffing and restricted 
infrastructural and microbiological support render diag-
nosis and prevention of infections in neonatal units chal-
lenging. A shift to facility- based deliveries may have had the 
adverse consequence of rendering babies vulnerable from 
birth to bacteria typically associated with prolonged admis-
sions (eg, multidrug- resistant Gram- negative organisms 
causing sepsis in the first 24 hours of life).7
Pilot work in Malawi using and codeveloping the NeoTree 
alpha version suggested a high degree of user satisfaction 
with NeoTree, with feedback used to upgrade the plat-
form to a beta version: Minimal Viable Product (MVP-1). 
NeoTree has the potential to streamline record keeping, 
feed back results and contribute to improved sepsis surveil-
lance, as well as providing guidance to clinicians about 
management of neonatal diagnoses. We piloted the beta 
version (MVP-1) of the NeoTree at HCH neonatal unit and 
additionally developed the laboratory data collection pages. 
We hypothesised that a novel app page for feeding back 
blood culture results from the laboratory to the neonatal 
unit could reduce test turnaround times. Establishing 
NeoTree as a robust data collection platform and a tool for 
antimicrobial surveillance could be a first step in instigating 
national level surveillance and antimicrobial stewardship.
MEASUREMENT
Our setting was HCH neonatal unit, with the population 
being all admitted neonates over a 9- month pilot period 
(November 2018–July 2019).
Four months prior to implementation of NeoTree, a 
prospective audit was carried out over a month to measure 
baseline admission/discharge rates and case fatality rates, 
antibiotic prescription rates, blood culture results and 
turnaround time.1 The previous standard of documenta-
tion to collect total numbers of admissions/discharges and 
deaths was a handwritten book, completed by the sister- 
in- charge. There were 459 admissions over 28 days with a 
case fatality rate of 210 per 1000 neonates admitted. Blood 
culture results were fed back in a median of 6 days, with 
only 7/196 (4%) cultures turned around in time to impact 
on therapy. Oral amoxicillin at discharge was prescribed 
for nearly all babies despite a lack of evidence for efficacy, 
though this dropped to 1/161 babies at repeat audit with 
intensive education for junior doctors prior to NeoTree 
introduction.1
Our aim for this quality improvement project was to 
demonstrate proof of concept of NeoTree as a real- time data 
capture tool, with digital forms completed by junior doctors 
replacing handwritten paper admission and discharge 
notes over 9 months and to provide monthly results to the 
neonatal unit. The primary endpoint measurement was to 
measure the number of admissions, discharges and deaths 
captured on NeoTree when compared with the current 
standard of documentation within the unit: the admission/
discharge/death handwritten book. Our target was for 
100% of admissions, discharges and deaths to be recorded 
on the NeoTree app at 9 months. Blood culture results 
turnaround time was to be measured and compared with 
the baseline data result.
To measure the ability to provide monthly data to 
the neonatal unit staff by month 6, we targeted month 
3 to commence formal monthly data feedback meetings 
(allowing time to ensure a robust data cleaning pipeline), 
taking a register of staff attendance and implement a 
culture of learning and feedback within these sessions. 
The sessions were to involve presentation of monthly data 
and feedback on the usability of NeoTree with suggestions 
documented and instigated promptly. Informal usability 
feedback was planned from day 1 to ensure a smooth 
roll- out and staff buy- in.
For data collection during the project, NeoTree- Beta 
acted as a real- time data collection tool, with pseudony-
mised data from each admission and discharge form being 
stored on the tablet after a hard, patient- identifiable copy 
was printed for the notes (currently only paper- based 
notes have legal standing in Zimbabwe). Eleven 8 GB 
Amazon Fire 7th generation (2017 release) tablets were 
supplied. Pseudonymised data were exported daily from 
tablets by the NeoTree Ambassador to a secure server 
where data were collated and analysed monthtly using 
R V.3.6.0 (R Core Team, Vienna, Austria) with RStudio 
V.1.2.1335 (RStudio Team, Boston, USA).8 Although 
NeoTree has the functionality to export automatically to 
a cloud server on record completion, Ministry of Health 
conditions were that a local server must be used, rather 
than a commercial platform. As data were exported daily, 
there was protection against large- scale data loss, but on 
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two occasions tablets crashed causing data loss of seven 
patients in total. For the laboratory page (NeoLab), labo-
ratory staff would enter blood culture results onto the 
laboratory tablet when available including preliminary 
negative results at 48 hours. These results were printed 
immediately on the neonatal unit via a WiFi connection 
where the junior doctors could collect them and file them 
in patient notes. Time of filing in notes was collected.
DESIGN
The team consisted of Zimbabwean and UK members. 
UK members were clinicians, software developers and 
statisticians, while Zimbabwean team members were 
consultant clinicians and senior laboratory scientists 
at HCH and the University of Zimbabwe. UK members 
were responsible for ongoing software development in 
response to clinician feedback, data management and 
overall project logistics. Prior to implementation, a round 
of informal usability testing was completed. This involved 
staff completing an admission and discharge form using 
the app and giving feedback. This feedback informed 
country and facility- specific adjustments to the Malawi 
NeoTree MVP-1 to produce ‘Zimbabwe MVP-2’. The 
format of the NeoTree admission/discharge pages were 
altered using an editor platform, which requires minimal 
software expertise to use (ie, without having to consult 
the software team) to account for specific unit needs. 
Zimbabwean team members tailored the clinical manage-
ment pages to ensure local relevance.
We hired a staff member, a research nurse with a degree 
in nursing (the ‘NeoTree Ambassador’) responsible for 
checking tablets in and out of the secure storage locker, 
charging tablets, data export, day- to- day supervision of 
the junior doctors to ensure the forms were correctly 
filled out, checking all babies admitted/discharged were 
being captured, training new staff members and acting 
as a project advocate within the unit (eg, explaining the 
project to families).2
Based on previous experience in Malawi,2 we planned 
to implement the Zimbabwe NeoTree MVP-2 over 4 
weeks, initially with a few admissions/discharges with 
each junior doctor per day supported by the study coor-
dinator/ambassador, then unsupervised day time admis-
sions/discharges, followed by weekends and night shifts 
until all admissions/discharges would be captured. Each 
junior doctor/laboratory staff member was trained by the 
study coordinator/NeoTree ambassador prior to being 
allocated a tablet. Discharge and laboratory forms were 
to be matched with admission forms using a unique iden-
tifier (NeoTree number) generated by the app on admis-
sion. Prior to implementation, we carried out five 45 min 
sensitisation training sessions for nurses, student nurses, 
cleaners and administrative staff to ensure buy- in and 
enable all staff to answer questions that family members 
might have. We were inclusive across staff cadres as our 
experience in Malawi revealed that mothers might be 
more comfortable raising concerns with lower rather 
than higher staff cadres (eg, asking questions to cleaners 
rather than nurses).2 In Malawi, some parents had 
thought the nurses were ‘playing games’ on the tablets 
rather than working, a misconception we were keen to 
avoid. Training feedback was enthusiastic, with the most 
common query being when would NeoTree be extended 
to include nursing observations. We held a monthly 
feedback session to present key indicator data and to 
encourage suggestions about potential improvements to 
the app and quality improvement questions that the data 
could be used for. Small monthly cash prizes were to be 
awarded to the junior doctor producing the most accurate 
‘NeoTrees’ each month (ie, the number of admission and 
discharge/death forms accurately completed). Sugges-
tions for app improvements were also encouraged on a 
day- to- day basis from junior doctors, and where feasible, 
these were rapidly incorporated within the app scripts to 
encourage local ownership and satisfaction, usually by the 
clinician project coordinator using the editor platform. It 
was rarely necessary to involve the software team in edits.
Ensuring the application was locally relevant was a key 
strategy for future- proofing the app. We were keen to 
make the app as useful as possible for the junior doctors 
and to encourage locally led ideas for quality improve-
ment. Another part of planning for future sustainability 
was engaging with the Zimbabwean Ministry of Health 
and Child Care who had an established Electronic 
Medical Records Department. They had not yet devel-
oped a neonatal ‘module’ and so were keen to discuss 
how NeoTree could be embedded within local systems for 
future wider roll out.
STRATEGY
Leadership and co-development
Our strategy for roll out depended heavily on leader-
ship within the unit. The medical and nursing senior 
team were enthusiastic about the platform’s potential 
to improve care and data collection and provided vital 
support to the junior doctors using the tablets. They also 
provided a real- time system of quality control: if there 
were inaccuracies or omissions on the printed admission 
form within the patient notes, these were picked and fed 
back up by seniors during daily ward rounds. Similarly, 
discharge summaries were reviewed in follow- up clinics 
and in unit spot checks by senior clinicians. The project 
coordinator directly canvassed opinions from junior 
doctors/nurses about potential improvements and prob-
lems, initially on a daily, then weekly, then monthly basis, 
although the NeoTree ambassador was available every day 
to answer queries, troubleshoot and collect suggestions 
from staff. At a higher level, interactions with hospital 
administrative staff were led by the local Principal Inves-
tigatorPI, with care taken to provide frequent reports 
and feedback on the project’s progress. Administrative 
staff were enthusiastic about the principle of digitising 
patient records while maintaining the printed copies of 
NeoTree admissions and discharges (therefore fulfilling 
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the legal obligation of having hard copy medical notes). 
Concerns about data ownership and storage were allayed 
by conservative data handling—storing data on an onsite 
server in the hospital rather than a commercial ‘cloud’.
Implementation lessons
The monthly data feedback sessions acted as host for our 
progressive improvement cycles. From the laboratory 
side, there were considerable hurdles with availability of 
culture media and then with staffing issues (see ‘lessons 
and limitations’ section). Industrial action also impacted 
the neonatal unit. We undertook five separate plan–do–
study–act (PDSA) cycles during the 9- month period.
PDSA 1: revision of death discharge forms
In month 2, we noted incomplete capture of deaths on 
NeoTree, when the number of deaths on NeoTree and 
in the handwritten death/discharge book recorded by 
the sister- in- charge were compared. Of 154 deaths docu-
mented from months 1–3, 143 (93%) were completed 
retrospectively by the NeoTree ambassador. Feedback 
from juniors highlighted that although the admission/
discharge electronic form replaced the paper forms, the 
NeoTree death forms were duplicates of effort as stat-
utory reporting of deaths mandated that deaths were 
documented on government forms which could not be 
replaced. We addressed this by intensifying scrutiny by 
NeoTree staff to ensure all babies who died were captured 
within the app, liaising directly with juniors and empha-
sising the importance of data entry (with support of senior 
clinical staff). We also altered the monthly prize to incen-
tivise the input of deaths onto the NeoTree (splitting one 
$20 prize to two $10, one each for most completed admis-
sions and discharges and one for deaths specifically). 
Over the next 2 months, the capture of deaths improved, 
although still needing ongoing input from NeoTree staff. 
Unfortunately, at month 7, it was found that the number 
of deaths documented had again decreased and particu-
larly babies dying very shortly after admission were not 
being captured. We instigated a rigorous simple audit 
programme with support of senior clinical staff to ensure 
every admitted baby (either on the NeoTree, in the nurses’ 
admission book or in the ‘death’ book had an outcome 
documented) and allowed a shortened discharge/death 
form to be completed without a separate admission form 
to be completed for these babies. Online supplemental 
figure 1 demonstrates the trend of death documentation 
throughout the project.
During the study, we commenced discussions with 
senior hospital management and the Ministry of Health 
to allow a NeoTree printout to be acceptable as formal 
death documentation. We believe while there is still dupli-
cation of effort, death documentation will be a weakness 
of NeoTree needing continuous monitoring and team 
input.
PDSA 2: revision of NeoTree ID number
By month 3, we found a high number of ‘unmatched’ 
discharge forms where the NeoTree ID entered on the 
discharge form had no corresponding NeoTree ID on an 
admission form. This was partly due to admission forms 
not being completed if the baby died shortly after admis-
sion (as mentioned under PDSA 1), but the percentage 
of unmatched discharge forms were still excessive. We 
found that NeoTree ID numbers were frequently entered 
incorrectly on the discharge form. We addressed this in 
month 4 partly via software changes using ongoing version 
control (software code available at https:// github. com/ 
neotree/ analytics)—shortening the 16- digit ID number 
to eight digits and using ‘fuzzy matching’ (a code string 
to find very near, but imperfect matches, eg, with one 
digit different) to match admissions/discharges based on 
common mismatches in the dataset where, for example, 0 
(number) and O (letter) had been confused. These were 
labelled as imperfect matches within the dataset. We also 
further amended the monthly prizes to include a ‘league 
table’ of highest percentage matches by junior doctors. 
This successfully reduced the number of NeoTree ID 
mismatches, dropping from 44% unmatched to <10% 
unmatched (figure 1). A small increase in unmatched 
records in month 8 was traced back to an individual new 
starter who received remedial training with good effect.
In a current parallel project, we are investigating the 
use of record linkage techniques, including probabi-
listic record linkage,9 to improve record matching and 
to increase the proportion of matched admission and 
discharge files. The next iteration of the NeoTree app has 
built- in functionality to match ID numbers with currently 
admitted patients at discharge to minimise mismatch risk.
PDSA 3: antibiotic prescription rates at discharge
Each month, we reviewed statistics suggested by medical/
nursing staff. For example, in month 5, it was requested 
that we review amoxicillin prescription at discharge and 
found the figures to have increased again to 78/354 
(22%) of discharged babies since the previous audit. We 
undertook further training for doctors and nurses in the 
principles of antimicrobial stewardship in low- income 
and middle- income countries10 and the lack of rationale 
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for amoxicillin use. This training was carried out over 
1 month, informally on ward rounds and formally during 
weekly unit teaching sessions to doctors and nurses, and 
included amoxicillin statistics in the regular feedback at 
the monthly meeting. The rate of amoxicillin prescrip-
tion reduced to 8/359 (2%) the following month and 
has remained low, although scrutiny is ongoing (online 
supplemental figure 2).
PDSA 4: thermoregulation data
Hypothermia at admission was another key indicator. 
Initially, this indicator was often missing. Temperatures 
were routinely taken by nursing staff on admission to the 
unit rather than junior doctors on initial examination of 
the newborn baby of the baby (eg, in the labour ward) so 
this was often left blank. Under 40% of babies in months 
2–3 had temperatures recorded. We supplied thermome-
ters for the two doctors on- call and made the data entry 
field mandatory (not optional), which improved the docu-
mentation. Subsequently, the percentage of babies with 
temperatures recorded at initial examination increased 
to 90% (month 8, figure 2).
From discussions with unit staff, it was felt that most 
babies admitted with hypothermia were outborn, not 
inborn. However, we showed that the majority of babies 
who were hypothermic were actually inborn and imple-
mented a programme of ensuring that small, premature 
babies were supported with adequate temperature control 
(online supplemental figure 3). This is an ongoing project 
as we have not yet seen an improvement in temperatures 
at admission (online supplemental figure 4). We believe 
this is partly due the Zimbabwean season in which the 
PDSA cycle commenced (meaning ambient temperatures 
can be 5°C at night) and partly to do with the doctor’s 
strike.
PDSA 5: sepsis surveillance
We set up the NeoLab forms to overcome the issues 
described in the ‘Problem’ section of logistical hurdles 
leading to lengthy turnaround times for blood cultures, 
the test used to confirm neonatal sepsis. Initially, there 
was enthusiasm from laboratory staff meaning in the first 
6 weeks, we cut median turnaround time to 3 days, but 
this was followed by 5 months of unavailability of culture 
media. Once culture media was available, laboratory staff 
had adopted ‘flexible working’ owing to disputes over 
wages, which led in turn to laboratory staff feeling too 
overstretched to fill in the NeoLab page (despite the page 
taking only a few seconds longer to complete than the 
paper form) and morale being low. We attempted rein-
vigorating staff with daily visits and encouragement from 
the NeoTree ambassador and engagement of the head 
of laboratories who was supportive although few inroads 
were made. The most recent iteration of this PDSA cycle 
is the naming of NeoTree Champion within the labora-
tory who will have personal responsibility for completing 
the forms in return for a small monthly stipend. This 
cycle remains ongoing.
As this was a quality improvement project aimed at 
strengthening routine clinical care and data were pseud-
onymised, requirement for individual consent was waived.
RESULTS
We trained 41 junior doctors, 9 laboratory staff and sensi-
tised 94 nursing/midwifery staff. We presented prelim-
inary audit data at a national level and to the hospital 
executive. There were 3222 admissions and discharges/
deaths of babies entered using NeoTree software, despite 
a 6- week doctor strike and a national shutdown including 
cessation of the internet nationwide. Monthly admission, 
discharge and mortality data are shown in figure 3. We 
fulfilled aims 1 and 2 by providing admission, discharge 
and death data on a monthly basis for the unit including 
statistics required by hospital management, such as 
mortality by term/preterm and birth weight, causes of 
death, receipt of prevention of mother- to- child transmis-
sion therapy for HIV and admission/discharge diagnoses 
(online supplemental table 1). Meetings were attended 
by between 15–30 medical, nursing and administrative 
staff from junior and senior cadres.
We fulfilled aim 3, providing data for locally led Quality 
Improvement (QI) projects such as antimicrobial stew-
ardship, which has resulted in a sustained decrease of 
unnecessary prescriptions of oral amoxicillin at discharge 
(online supplemental figure 2). Adherence to appro-
priate first line antimicrobial therapy has improved: at 
baseline, 9% of babies received ceftriaxone as opposed to 
crystalline penicillin and gentamicin. At last review, 1.5% 
of babies received ceftriaxone as first- line therapy. The 
hypothermia QI project is ongoing.
However, aim 4, the laboratory arm of the project 
continues to be more challenging and has not yet been 
fulfilled. Initially, we reduced laboratory turnaround 
time for blood culture results from 6 days to 3 days 
within the first 6 weeks of introduction. However, this 
was not sustained (see Lessons and limitations), and the 
Figure 2 Percentage of babies with their temperature 
measured at admission throughout the project.
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current turnaround time for results to be fed back using 
the NeoTree is between 6 and 10 days, with laboratory 
staff feeding back that they have no earlier opportunity 
to fill in the NeoTree form. We have unfortunately also 
had such incomplete laboratory data that we have not yet 
been able to develop the surveillance platform.
The NeoTree data are currently being used for two 
locally led quality improvement projects: management 
of congenital syphilis and management of late preterm 
infants. In addition, NeoTree data will be used in Zimba-
bwean- led research projects in neonatal sepsis, antenatal 
steroid use and hypothermic ischaemic encephalop-
athy (this last project in conjunction with developing 
a platform for labouring mothers with Zimbabwean 
obstetricians—the ‘MummyTree’). We are in advanced 
discussions with the Ministry of Health about how to 
incorporate the NeoTree into their plans for nationwide 
electronic medical record roll out.
Lessons and limitations
The most challenging aspect of the project was the labo-
ratory side. After an initial 6 weeks where we improved 
turnaround time, there were then 5 months of issues with 
media availability, meaning no cultures were performed. 
When the media finally became available again, economic 
upheaval and industrial action led to a policy of ‘flexible 
working’ in the laboratory, meaning skeleton staffing 
became the norm. Despite financial incentives from the 
NeoTree, project morale was very low, and it was increas-
ingly challenging to motivate staff to complete the labo-
ratory form. Further interventions are ongoing, but this 
aspect of the project has suffered from force majeure. By 
contrast, despite industrial action by junior doctors in 
months 2–3, the remaining skeleton junior staff (two out 
of a rostered eleven) were strong advocates for NeoTree 
and continued to use it although more for discharges 
than admissions. This meant when the full staffing 
complement returned in January 2019, using NeoTree 
was the departmental norm, and there was considerable 
peer- to- peer training in addition to that provided by 
NeoTree staff. In general, the junior doctors were familiar 
with touchscreen technology and quick to learn the 
process of using the app and printing the forms. Availa-
bility of reliable WiFi provision (needed for connecting 
tablets to a printer and exporting data) and power was 
key. These facilitating factors may not be reproducible 
in other settings, particularly power and the staff cadres 
using NeoTree. The app is designed to work offline with 
data exported intermittently, maintaining the education 
functionality, although alternative printing arrangements 
such as Bluetooth options would need to be in place. A 
variety of staff cadres found NeoTree to be highly ‘usable’ 
in Malawi, although with more training.2
CONCLUSION
We have shown the NeoTree app to be an effective tool for 
data capture, replacing handwritten paper- based admis-
sion and death/discharge forms within HCH neonatal 
unit. The data captured were routinely fed back to the 
unit during monthly presentations, when regular feed-
back was taken about the app, with subsequent iterative 
improvements made and further locally driven quality 
improvement projects commenced. These data were 
presented at hospital executive and national levels. Anti-
microbial stewardship was supported by effective surveil-
lance of amoxicillin at discharge. However, despite the 
successful integration of the NeoTree into the neonatal 
unit, the laboratory arm suffered from challenges often 
encountered in low- income settings, namely economic 
upheaval, industrial action and shortages of supplies. We 
are continuing to work towards our aim of implementing 
a sepsis surveillance platform.
The NeoTree app has been embedded into usual clin-
ical practice for admission and death/discharge docu-
mentation, with the monthly presentations now normal 
practice within the unit, guiding and changing local prac-
tice with minimal external input from the NeoTree team. 
An essential factor for this success was strong local lead-
ership, which will also be key in long- term sustainability. 
Regular feedback and the ability to adapt to local needs is 
a vital attribute of the NeoTree project. The next steps are 
planned piloting in a provincial hospital to test usability 
in a nurse- led unit using the iterative PDSA processes 
as described previously. Economic analysis (currently 
ongoing) will be crucial to ensure feasible and sustain-
able further roll- out as well as ensuring the platform is 
robust in a wider variety of settings. Close cooperation 
and coordination with Ministries of Health will also be 
key to ensuring sustainability in Zimbabwe and elsewhere.
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